$2.40
1.44%
Nasdaq, Sep 18, 04:00 pm EDT. Closed.
ISIN
VGG2161P1080
Symbol
SXTC

China Sxt Pharmaceuticals, Inc. Stock price

$2.40
-2.73 53.22% 1M
-132.80 98.22% 6M
-19,197.60 99.99% YTD
-22,797.60 99.99% 1Y
-311,517.60 100.00% 3Y
-47,966,397.60 100.00% 5Y
-1,102,079,997.60 100.00% 10Y
-1,102,079,997.60 100.00% 20Y
Nasdaq, Closing price Fri, Sep 18 2026
-0.04 1.44%
ISIN
VGG2161P1080
Symbol
SXTC
Industry

Is China Sxt Pharmaceuticals, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
$3.2m
Enterprise Value
$-24.0m
Net debt
positive
Cash
$28.2m
Shares outstanding
10.0k
Valuation (TTM | estimate)
P/E
negative
P/S
2.8 | -
EV/Sales
negative | -
EV/FCF
4.6
P/B
0.1
Financial Health
Equity Ratio
85.5%
Return on Equity
-20.9%
ROCE
-23.4%
ROIC
-191.5%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$1.1m | -
EBITDA
$-7.1m
EBIT
$-7.1m
Net Income
$-6.2m
Free Cash Flow
$-5.3m
Growth (TTM | estimate)
Revenue
-34.5% | -
EBITDA
-171.2%
EBIT
-165.7%
Net Income
-88.2%
Free Cash Flow
-124.3%
Margin
Gross
21.9%
EBITDA
-619.4%
EBIT
-625.9%
Net
-545.2%
Free Cash Flow
-462.9%
More
EPS
$-847.7
FCF per Share
$-526.8
Short interest
1.4%
Employees
75
Rev per Employee
$20.0k

Financial data from China Sxt Pharmaceuticals, Inc.

Mar '26
+/-
%
1.14 1.14
34% 34%
100%
- Direct Costs 0.89 0.89
35% 35%
78%
0.25 0.25
32% 32%
22%
- Selling and Administrative Expenses 7.37 7.37
142% 142%
646%
- Research and Development Expense - -
-
-
-7.05 -7.05
171% 171%
-618%
- Depreciation and Amortization 0.07 0.07
13% 13%
6%
EBIT (Operating Income) EBIT -7.12 -7.12
166% 166%
-625%
Net Profit -6.21 -6.21
88% 88%
-545%

In millions USD.

Don't miss a Thing! We will send you all news about China Sxt Pharmaceuticals, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

China Sxt Pharmaceuticals, Inc. Stock News

Neutral
GlobeNewsWire
about 2 months ago
TAIZHOU, China, Aug. 05, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (the “Company”), today announced that it will effect a share consolidation of its Class A ordinary shares, no par value per share, and Class B ordinary shares no par value per share, at a ratio of 1-for-80, effective on August 10, 2026 (the “Share Consolidation”). The Company's Class A ordinary shar...
Neutral
GlobeNewsWire
about 2 months ago
New York, July 24, 2026 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New York, today announced the closing of a registered direct offering (the “Offering”) of approximately $9 million for its client China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the "Company"), a China-based inn...
Neutral
GlobeNewsWire
about 2 months ago
TAIZHOU, China, July 23, 2026 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals Inc. (NASDAQ: SXTC) (the “Company”), today announced that it has entered into a definitive securities purchase agreement with certain institutional investors for the purchase and sale of an aggregate of 4,500,000 units (each, a “Unit”), consisting of one Class A ordinary share of the Company, no par value per share (eac...
More China Sxt Pharmaceuticals, Inc. News

Company Profile

China Sxt Pharmaceuticals, Inc. is a holding company, which engages in the research, development, manufacture, marketing and sales of traditional Chinese medicine pieces (TCMP). Its product categories includes directly-oral, after-soaking-oral, fine, and regular TCMP. It distributes its product under the Suxuantang brand. The company was founded by Feng Zhou in 2005 and is headquartered in Taizhou, China.

Head office Virgin Islands, British
CEO Mr. Zhou
Employees 75
Founded 2005
Website www.sxtchina.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today